Annette Stein

Suggest Changes
Learn More
PURPOSE Low-dose (LD) interferon (IFN) alfa (LDI) has demonstrated a consistent disease-free survival benefit for patients with clinically lymph node-negative melanoma in clinical trials. However,(More)
4554 Background: Combination regimens of 3 drugs have shown promising activity as treatment for patients (pts) with metastatic gastric cancer (GC). Docetaxel combined with cisplatin and 5-FU (CF)(More)
Background In most countries, approved botulinum toxin type A formulations require reconstitution before injection. Objectives To evaluate the efficacy and safety of a ready-to-use liquid(More)